Araris Biotech News and Activities

Araris Biotech is owned by Otsuka Holdings.

Otsuka Holdings is one of the...

• Forbes Global 2000 (#654);
• Nikkei 225;
• TOB Iconic 10,000;
• Topix.

Otsuka Holdings is a company listed under the stock ticker 4578 (JP).

Otsuka Holdings has a direct presence in 11 countries.

Otsuka Holdings has 23 subsidiaries including Araris Biotech, Cambridge Isotope Laboratories and Interpharma.

They are in:

• Pharmaceuticals46%
• Medical Equipment29%
• Other25%

Acquisition, funding and merger involving Otsuka Holdings.

• Taiho Pharmaceutical has announced the acquisition of Araris Biotech  (posted on April 3 2025).

View the org chart displaying its 11 main executives

Most searched biographies at Araris Biotech

• Dragan Grabulovski, Co-Founder and Chief Executive Officer
• Arnd Kaltofen, Director
• Michael Sidler, Director

Create your alert
to follow the executive moves at Araris Biotech.

Otsuka Holdings has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Araris Biotech

Social media about Araris Biotech

• Araris Biotech on Wikipedia, Google News & Yahoo Finance
• Araris Biotech on LinkedIn, X (Twitter) & YouTube